Marie-Astrid Hoogerwerf
8PUBLICATIONS
33CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Apr 02, 2026
Advances in vaccine development through the controlled human infection models for hookworm and schistosomiasis.Marie-Astrid Hoogerwerf, Moses Egesa, Selidgji Todagbe Agnandji
|Jan 24, 2025
Safety, Tolerability, and Immunogenicity of the InvaplexAR-DetoxShigella Vaccine Co-Administered with the dmLT Adjuvant in Dutch and Zambian Adults: Study Protocol for a Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Phase Ia/b Clinical Trial.Geert V T Roozen, Nsofwa Sukwa, Masuzyo Chirwa
|Nov 07, 2024
What motivates SARS-CoV-2 vaccine trial participants? A pre- and post-participation survey study.Olivia A C Lamers, Meta Roestenberg, Martine C de Vries
|Jul 16, 2024
Controlled human hookworm infection remodels plasmacytoid dendritic cells and regulatory T cells towards profiles seen in natural infections in endemic areas.Mikhael D Manurung, Friederike Sonnet, Marie-Astrid Hoogerwerf
|Jul 05, 2024
Early symptom-associated inflammatory responses shift to type 2 responses in controlled human schistosome infection.Emma L Houlder, Koen A Stam, Jan Pieter R Koopman
|Jul 28, 2020
Money-oriented risk-takers or deliberate decision-makers: a cross-sectional survey study of participants in controlled human infection trials.Marie-Astrid Hoogerwerf, Martine de Vries, Meta Roestenberg
Pageof 2
Frequent Collaborators
4 joint publications
Meta Roestenberg
2 joint publications
Tom L Richie
2 joint publications
Maria Yazdanbakhsh
2 joint publications
Marion König
1 joint publications
Jona Walk
1 joint publications
Amanda Fabra García
1 joint publications
Leo G Visser
1 joint publications
André J A M van der Ven
1 joint publications
Michelo Simuyandi
1 joint publications
Stephen L Hoffman
